Garde Capital, Inc. Tekla Life Sciences Investors Transaction History
Garde Capital, Inc.
- $1.76 Billion
- Q1 2025
A detailed history of Garde Capital, Inc. transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Garde Capital, Inc. holds 100 shares of HQL stock, worth $1,204. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100Holding current value
$1,204% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HQL
# of Institutions
81Shares Held
9.67MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.43MShares$41.3 Million1.11% of portfolio
-
Penserra Capital Management LLC Orinda, CA828KShares$9.96 Million0.2% of portfolio
-
Karpus Management, Inc. Pittsford, NY490KShares$5.89 Million0.23% of portfolio
-
Sit Investment Associates Inc Minneapolis, MN417KShares$5.02 Million0.12% of portfolio
-
Absolute Investment Advisers LLC400KShares$4.81 Million0.67% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...